skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
JEB Regimen (Code C67289)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: JEB Regimen

Definition: A regimen consisting of bleomycin, etoposide and carboplatin used to treat advanced-stage ovarian and testicular germ-cell tumors in children.

NCI-GLOSS Definition: An abbreviation for a chemotherapy combination used to treat childhood ovarian and testicular germ cell cancers that have spread. It includes the drugs carboplatin (JM8), etoposide phosphate, and bleomycin sulfate.

Label: JEB Regimen

NCI Thesaurus Code: C67289 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1881289  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Bleomycin-Etoposide-Carboplatin Regimen
Carboplatin-Etoposide-Bleomycin Regimen
JEB Regimen
JEB regimen
JM8-Etoposide-Bleomycin Regimen

External Source Codes: 
PDQ Closed Trial Search ID 657033
PDQ Open Trial Search ID 657033 (check for NCI PDQ open clinical trial info)
UMLS CUI C1881289

Other Properties:
     Name Value (qualifiers indented underneath)
code C67289
DesignNote Source: NCCN Guidelines 2007 and PDQ (testicular and childhood germ-cell tumors)
Legacy_Concept_Name JEB_Regimen
Semantic_Type Therapeutic or Preventive Procedure

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom